The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Loukianov M.M.

National Medical Research Center for Therapy and Preventive Medicine

Gomova T.A.

Regional Clinical Hospital

Shepel R.N.

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of the Russia

Andreenko E.Yu.

National Medical Research Center for Therapy and Preventive Medicine

Smirnov A.A.

National Medical Research Center for Therapy and Preventive Medicine

Okshina E.Yu.

National Medical Research Center for Therapy and Preventive Medicine

Kuzina N.N.

National Medical Research Center for Therapy and Preventive Medicine

Soplenkova A.G.

National Medical Research Center for Therapy and Preventive Medicine;
Lomonosov Moscow State University

Stepanova E.V.

Tula Regional Clinical Hospital

Valiakhmetov M.N.

Tula Regional Clinical Hospital

Savishceva A.A.

Regional Clinical Hospital

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital monitoring

Authors:

Loukianov M.M., Gomova T.A., Shepel R.N., Andreenko E.Yu., Smirnov A.A., Okshina E.Yu., Kuzina N.N., Soplenkova A.G., Stepanova E.V., Valiakhmetov M.N., Savishceva A.A., Drapkina O.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(11): 36‑44

Read: 632 times


To cite this article:

Loukianov MM, Gomova TA, Shepel RN, et al. Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital monitoring. Russian Journal of Preventive Medicine. 2025;28(11):36‑44. (In Russ.)
https://doi.org/10.17116/profmed20252811136

Recommended articles:
Myokines — the cardiometabolic risk pote­ntial biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):119-126
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104

References:

  1. Khan SS, Abdalla M, Bello NA, et al. Use of Risk Assessment to Guide Decision Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2025;1 52:e00-e00.  https://doi.org/10.1161/CIR.0000000000001355
  2. Lukyanov MM, Boytsov SA, Yakushin SS, et al. The outpatient based registry RECVASA: prospective follow-up data, risk evaluation and outcomes in cardiovascular patients. Kardiovaskuljarnaja terapija i profilaktika. 2015; 14(1):53-62. (In Russ.). https://doi.org/10.15829/1728-8800-2015-1-53-62
  3. Lukyanov MM, Martsevich SYu, Yakushin SS, et al. Remote outcomes in patients with cardiovascular diseases in outpatient practice: data from a 10-year follow-up within the RECVAZA registry. Kardiovaskuljarnaja terapija i profilaktika. 2024;23(12):42-69. (In Russ.). https://doi.org/10.15829/1728-8800-2024-4269
  4. Bhatnagar P, Wickramasinghe K, Wilkins E, et al. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102(24):1945-1952. https://doi.org/10.1136/heartjnl-2016-309573
  5. Drozd M, Pujades-Rodriguez M, Sun F, et al. Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study. Journal of the American Heart Association. 2021;10(22):e023188. https://doi.org/10.1161/JAHA.121.023188
  6. Драпкина О.М., Концевая А.В., Калинина А.М. и др. Коморбидность пациентов с хроническими неинфекционными заболеваниями в практике врача-терапевта. Евразийское руководство. Кардиоваскулярная терапия и профилактика. 2024;23(3):36-96. 
  7. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Comorbidity of patients with noncommunicable diseases in general practice. Evrazijskoe rukovodstvo. Kardiovaskuljarnaja terapija i profilaktika. 2024;23(3):36-96. (In Russ.). https://doi.org/10.15829/1728-8800-2024-3996
  8. Loukianov MM, Gomova TA, Savishceva AA, et al. RegiStry Of the multiFaceted medIcal cenTer (SOFIT): the main tasks, development, and the first results. Russian Journal of Preventive Medicine. 2023;26(6):46-54. (In Russ.). https://doi.org/10.17116/profmed20232606146
  9. Vinjerui KH, Bjorngaard JH, Krokstad S, et al. Socioeconomic Position, Multimorbidity and Mortality in a Population Cohort: The HUNT Study. Journal of Clinical Medicine. 2020;9(9):2759. https://doi.org/10.3390/jcm9092759
  10. van Oostrom SH, Gijsen R, Stirbu I, et al. Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS One. 2016;11(8):e0160264. https://doi.org/10.1371/journal.pone.0160264
  11. Williams JS, Egede LE. The Association between Multimorbidity and Quality of Life, Health Status and Functional Disability. American Journal of Medical Sciences. 2016;352(1):45-52.  https://doi.org/10.1016/j.amjms.2016.03.004
  12. Rodrigues LP, de Oliveira Rezende AT, Delpino FM, et al. Association between multimorbidity and hospitalization in older adults: systematic review and meta-analysis. Age and Ageing. 2022;51(7):afac155. https://doi.org/10.1093/ageing/afac155
  13. Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015; 314(1):52-60.  https://doi.org/10.1001/jama.2015.7008
  14. Coste J, Valderas JM, Carcaillon-Bentata L. Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in France. PLoS Medicine. 2021;18(4):e1003584. https://doi.org/10.1371/journal.pmed.1003584
  15. Excoffier S, Herzig L, N’Goran AA, et al. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss sentinel surveillance system (Sentinella). BMJ Open. 2018;8(3):e019616. https://doi.org/10.1136/bmjopen-2017-019616
  16. Lochner KA, Cox CS. Prevalence of multiple chronic conditions among medicare beneficiaries, United States, 2010. Preventing Chronic Disease. 2013;10:E61.  https://doi.org/10.5888/pcd10.120137
  17. Miller PE, Thomas A, Breen TJ, et al. Prevalence of Noncardiac Multimorbidity in Patients Admitted to Two Cardiac Intensive Care Units and Their Association with Mortality. American Journal of Medicine. 2021;134(5):653-661.e5.  https://doi.org/10.1016/j.amjmed.2020.09.035
  18. Zhou Z, Shi M, Liu M, et al. Multimorbidity in Hospitalized Patients Admitted to General Practice Departments and Its Implications for the General Practice Healthcare System: A Four Year Longitudinal Study in China. Frontiers in Public Health. 2021;9:760792. https://doi.org/10.3389/fpubh.2021.760792
  19. Özcan C, Deleskog A, Schjerning Olsen AM, et al. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study. European Heart Journal. Cardiovascular Pharmacotherapy. 2018;4(1):25-35.  https://doi.org/10.1093/ehjcvp/pvx009
  20. Jernberg T, Hasvold P, Henriksson, et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal. 2015;36(19): 1163-1170. https://doi.org/10.1093/eurheartj/ehu505
  21. Han X, Jeong MH, Bai L, et al. Other KAMIR-NIH Registry Investigators. Long term clinical outcomes of Type 1 vs. Type 2 myocardial infarction in patients who underwent angiography: data from the Korea acute myocardial infarction-national institute of health registry. Cardiovascular Diagnosis and Therapy. 2022;12(1):55-66.  https://doi.org/10.21037/cdt-21-434
  22. Cubbon RM, Gale CP, Kearney LC, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circulation. Heart Failure. 2011;4(4):396-403.  https://doi.org/10.1161/CIRCHEARTFAILURE.110.959882
  23. Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet. Oncology. 2017;18(8):e457-e471. https://doi.org/10.1016/S1470-2045(17)30411-4
  24. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:22152222. https://doi.org/10.1016/S0140-6736(10)60484-9
  25. Leavitt BJ, Ross CS, Spence B, et al. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery. Circulation. 2006;114(1_supplement):I-430-4.  https://doi.org/10.1161/CIRCULATIONAHA.105.000943
  26. Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 2018;198(1):51-57.  https://doi.org/10.1164/rccm.201711-2239OC
  27. Lukyanov MM, Kutishenko NP, Martsevich SYu, et al. Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry. Rossijskij kardiologicheskij zhurnal. 2022;27(3):4912. (In Russ.). https://doi.org/10.15829/1560-4071-2022-4912
  28. Loukianov MM, Andreenko EYu, Martsevich SYu, et al. Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry. Kardiovaskuljarnaja terapija i profilaktika. 2023;22(10):3757. (In Russ.). https://doi.org/10.15829/1728-8800-2023-3757
  29. Smirnov AA, Loukianov MM, Martsevich SYu, et al. Long-term outcomes in patients with cardiovascular multimorbidity suffered from COVID-19: two-year observation. Russian Journal of Preventive Medicine. 2023; 26(12): 58-64. (In Russ.). https://doi.org/10.17116/profmed20232612158
  30. Loukianov MM, Martsevich SYu, Kutishenko NP, et al. Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medicine. 2024;27(12):114-121. (In Russ.). https://doi.org/10.17116/profmed202427121114
  31. Mainous AG 3rd, Rooks BJ, Wu V, et al. COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk. Frontiers in Medicine. 2021; 8:778434. https://doi.org/10.3389/fmed.2021.778434
  32. Raisi-Estabragh Z, Cooper J, Salih A, et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022;109(2):119-126.  https://doi.org/10.1136/heartjnl-2022-321492
  33. Cai M, Xie Y, Topol EJ, et al. Three-year outcomes of post-acute sequelae of COVID-19. Nature Medicine. 2024;30:1564-1573. https://doi.org/10.1038/s41591-024-02987-8

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.